|Project Title||Principal Investigator||Institution|
|A sibling mediated imitation intervention for young children with autism||Meyer, Katherine||Michigan State University|
|Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)||Devane, C. Lindsay||Medical University of South Carolina|
|HCC: Collaborative research: Social-emotional technologies for autism spectrum disorders||Picard, Rosalind||Massachusetts Institute of Technology|
|3/3-Multisite RCT of early Intervention for spoken communication in autism||Landa, Rebecca||Kennedy Krieger Institute|
|Enhancing inter-subjectivity in infants at high risk for autism||Bryson, Susan; Brian, Jessica; Smith, Isabel; Zwaigenbaum, Lonnie; Roberts, Wendy||IWK Health Centre/Dalhousie University; University of Toronto; University of Alberta; The Hospital for Sick Children|
|IACC Strategic Plan Objective||2008||2009||2010||2011||2012||Total|
Launch randomized controlled trials of interventions including biological signatures and other measures to predict response, and monitor quality of life and functional outcomes in each of the following groups:
Total IACC Recommended Budget: $66,000,000 over 5 years
|4.3 & 4.4
16 projects & 30 projects
|4.S.F. Funding: The recommended budget was partially met.
Progress: The investment in projects under this objective is making good progress toward the recommended amount, with more than 20 projects funded in 2011 and 2012.
Remaining Gaps, Needs, and Opportunities: Current projects in this area are restricted to small pilot studies, which are essential to establishing a foundation prior to expansion to larger scale work. Thus, increased investment in this area is important. It should be noted that most RCTs in the future will incorporate some aspect of biological signatures (thus potentially presenting a challenge to future coding of projects).